Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 93950301000001119 | Netupitant (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 93950401000001110 | Netupitant | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Netupitant | Is a | Substance with neurokinin 1 receptor antagonist mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Netupitant 300mg / Palonosetron hydrochloride 500micrograms capsules | Has specific active ingredient | False | Netupitant | Inferred relationship | Existential restriction modifier | |
| Akynzeo 300mg/0.5mg capsules (Chugai Pharma UK Ltd) | Has specific active ingredient | False | Netupitant | Inferred relationship | Existential restriction modifier | |
| Netupitant 300mg / Palonosetron hydrochloride 500micrograms capsules 1 capsule | Has specific active ingredient | False | Netupitant | Inferred relationship | Existential restriction modifier | |
| Akynzeo 300mg/0.5mg capsules (Chugai Pharma UK Ltd) 1 capsule | Has specific active ingredient | False | Netupitant | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR